ReviewCureus2026
Coronary Artery Calcium Score as a Predictor of Cardiovascular Disease Events and Mortality Among Asymptomatic Working-Age Adults: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Coronary Artery Calcium (CAC) score is primarily used in asymptomatic individuals at intermediate risk for developing cardiovascular disease (CVD), particularly when there is uncertainty whether to initiate statins or intensify primary prevention measures. In this systematic review, we examined the value of the CAC score as a predictor of incident CVD events and mortality among asymptomatic working-age adults. We reviewed studies published from November 2009 to December 2022 examining asymptomatic adults 18-65 years of age. A total of 908 studies were identified. After the elimination of 578 and 326 studies based on abstract and full-text review, respectively, we examined four studies that met the inclusion criteria. Two of the studies showed that any CAC score above zero was associated with a four- to fivefold increased risk of incident cardiac events. In addition, we found that increasing CAC score was associated with a higher risk of incident cardiac events and/or all-cause mortality in a dose-response relationship documenting a strong criterion of causality. Furthermore, one of the studies elicited a higher discriminatory power of the CAC score compared to the Framingham and the Atherosclerotic Cardiovascular Disease (ASCVD) risk scores in distinguishing high-risk from intermediate-risk individuals for all-cause mortality. Our review showed that the CAC score is predictive of elevated risk for incident CVD events and mortality among asymptomatic working-age adults. However, prospective studies are warranted to perform cost-benefit analyses on the utility of CAC scoring as a screening tool in the general population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.